4.10MMarket Cap
0.00P/E TTM
Aptevo Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Aptevo Therapeutics Inc is 8.97, ranking 37 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is 0.00, which is 57539.29% below the recent high of 1.61 and 19817.86% above the recent low of -0.55.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.